# Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

> **NCT05775419** · NA · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 1216 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Chemotherapy Effect
- Side Effect of Drug

## Interventions

- **COMBINATION_PRODUCT:** Consolidation chemotherapy (4 courses)
- **COMBINATION_PRODUCT:** Concurrent chemotherapy (2 courses)

## Key facts

- **NCT ID:** NCT05775419
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 1216 (ESTIMATED)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05775419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05775419, "Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05775419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*